Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Eli Lilly and Company
Juvenile Idiopathic Arthritis
Argentina, Australia, Austria, Belgium, Brazil +15 more
- Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)Active Not Recruiting
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Canada, Germany, Japan, Poland +1 more
Sponsor: AstraZeneca
Locally Advanced Head and Neck Squamous Cell Carcinoma
United States, Austria, Belgium, Brazil, Canada +18 more
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Acute Myeloid Leukemia
United States, Australia, Belgium, Estonia, Finland +4 more
- Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency DiseasesActive Not Recruiting
Sponsor: Octapharma
Primary Immune Deficiency
United States, Germany, Hungary, Italy, Poland +2 more
Sponsor: Eli Lilly and Company
Ovarian Neoplasms · Breast Neoplasms · Pancreatic Intraductal Neoplasms · Colorectal Neoplasms
United States, China, Germany, Japan, Netherlands
- Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentActive Not Recruiting
Sponsor: AstraZeneca
Carcinoma · Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +22 more
Sponsor: Daiichi Sankyo
Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Jules Bordet Institute
Metastatic Breast Cancer
Belgium, Germany, Iceland, Italy, Luxembourg +5 more
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive Not Recruiting
Sponsor: AbbVie
Hematologic Cancer
United States, Canada, France, Germany, Israel +4 more
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 1
United States, Australia, Belgium, Brazil, Canada +13 more
Sponsor: Eli Lilly and Company
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
United States, Argentina, Belgium, Bulgaria, Canada +15 more
Sponsor: Kedrion S.p.A.
Chronic Primary Immune Thrombocytopenia (ITP)
United States, Czechia, Germany, Italy, Romania +3 more
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasm Malignant
United States, Brazil, Chile, China, Germany +6 more
Sponsor: Incyte Corporation
Chronic Graft-versus-host-disease
United States, Australia, Austria, Canada, Denmark +8 more
- The PEERLESS II StudyActive Not Recruiting
Sponsor: Inari Medical
Pulmonary Embolism
United States, Belgium, Canada, Denmark, France +4 more
Sponsor: Cristcot HCA LLC
Ulcerative Proctitis
United States, Bulgaria, China, Denmark, France +18 more
Sponsor: Amgen
Atopic Dermatitis
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: AstraZeneca
Resistant Hypertension
United States, Argentina, Australia, Belgium, Bulgaria +17 more
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +23 more
Sponsor: X4 Pharmaceuticals
Neutropenia
United States, Argentina, Australia, Belgium, Canada +20 more
Sponsor: Freya Biosciences ApS
Bacterial Vaginosis (BV)
Germany
Sponsor: Hoffmann-La Roche
Parkinson's Disease
United States, Australia, Austria, Brazil, Canada +12 more
Sponsor: University Hospital, Essen
Glioma
Germany
Sponsor: Bayer
Prostate Cancer
United States, Argentina, Austria, Belgium, Brazil +12 more